How to Improve Your Left Ventricular Ejection Fraction (LVEF)

Left ventricular ejection fraction can improve, sometimes dramatically, depending on the cause of the decline and the treatments pursued. People with heart failure and a reduced LVEF who receive standard medications see a median improvement of about 4 percentage points, while roughly half experience a jump of 5 points or more. For certain reversible conditions, LVEF can return entirely to normal. The range of strategies that move the number spans medications, exercise, lifestyle changes, procedures, and devices, and knowing which combination fits your situation makes all the difference.

What a Normal LVEF Looks Like

LVEF describes the percentage of blood your left ventricle pumps out with each heartbeat. Guidelines have traditionally placed the normal threshold at 55% or above, with the 50–55% range labeled “low normal.”¹ A recent meta-analysis of population-based echocardiographic studies found that the average LVEF in healthy adults is about 63%, with women slightly higher than men. Fewer than 1% of healthy women and only about 1% of healthy men have an LVEF below 50%.² When LVEF drops well below 50%, that signals the heart muscle is weakening, a process that involves muscle cell damage, scarring, inflammation, and structural remodeling of the heart chambers.³

Guideline-Directed Medications Are the Foundation

If you have heart failure with a reduced ejection fraction, the single biggest lever for LVEF improvement is medications. Standard heart failure drugs include beta-blockers, ACE inhibitors or angiotensin receptor-neprilysin inhibitors, mineralocorticoid receptor antagonists, and SGLT2 inhibitors. These work by easing the workload on the heart, blocking harmful stress hormones, and reducing fluid overload. When started together and gradually increased to target doses, they give the heart a chance to recover.

The improvement takes time. A large study of newly diagnosed heart failure patients found that at 90 days on these medications, about 46% had improved their LVEF above 35%. For those who had not recovered by day 90, nearly half went on to recover by day 180. By one year, roughly three-quarters of patients had achieved that threshold.⁴ That timeline matters: if your LVEF hasn’t budged at three months, it doesn’t mean the medications have failed. The heart muscle frequently needs six to twelve months before full recovery shows up on imaging.

A registry of outpatients with established heart failure and reduced ejection fraction paints a more conservative picture for people who are further along in their disease. About half of those patients saw at least a 5-point LVEF increase, and about a third saw a 10-point or greater increase, but nearly one in five actually experienced a decline.⁵ The difference between new and established heart failure is worth noting. Newly diagnosed hearts tend to be more responsive because the damage has had less time to become permanent.

Exercise Training

Structured exercise programs deliver measurable LVEF gains on top of what medications provide. In coronary artery disease patients who completed a cardiac rehabilitation program, the exercise group improved from about 47% to over 61%, while a control group saw no meaningful change.⁶ That trial studied patients after heart procedures who had mildly reduced function, and the gains were striking for that group.

For people with heart failure and reduced ejection fraction specifically, a meta-analysis pooling data from multiple trials found that high-intensity interval training improved LVEF by roughly 3.7 percentage points compared with no exercise.⁷ That sounds modest, but in a population already on heart failure medications, an additional few points reflects genuine cardiac remodeling. The same meta-analysis found no statistically significant difference between high-intensity intervals and continuous moderate exercise, so the best program is one you will actually stick with. Cardiac rehabilitation programs are typically supervised, which adds a layer of safety for people with weak hearts.

Alcohol, Diet, and Sleep

Certain lifestyle factors directly damage the heart or stress it in ways that suppress LVEF. Addressing them can unlock recovery that medications alone won’t achieve.

Alcohol is the clearest example. In people whose heart failure is caused by heavy drinking, stopping alcohol can lead to rapid functional recovery.⁸ A study of 100 patients with alcoholic cardiomyopathy found that 42% achieved substantial LVEF recovery over follow-up, defined as an increase of at least 10 points to a final LVEF of 40% or higher. Nobody who continued heavy drinking recovered. Interestingly, the rate of recovery was nearly identical between patients who quit entirely and those who reduced to moderate drinking.⁹ The takeaway is straightforward: if alcohol contributed to your heart failure, eliminating heavy consumption is non-negotiable for recovery.

Diet plays a supporting role. A sodium-restricted DASH-style eating pattern has been shown to improve diastolic function and the coupling between the heart and arteries in patients with heart failure and preserved ejection fraction.¹⁰ While that study focused on preserved, not reduced, ejection fraction, controlling blood pressure and fluid retention through diet supports cardiac recovery in general. Excessive salt intake forces your body to hold onto more fluid, which stretches heart chambers and makes pumping harder.

Obstructive sleep apnea is an underappreciated drag on LVEF. When you stop breathing repeatedly during sleep, your oxygen drops and your blood pressure spikes, putting chronic strain on the heart. A systematic review and meta-analysis found that continuous positive airway pressure (CPAP) improved LVEF by about 3.7 points overall in people with sleep apnea and reduced ejection fraction.¹¹ In patients with both sleep apnea and heart failure, the effect was larger: one earlier meta-analysis found CPAP improved LVEF by about 5 points in that subgroup, while patients with sleep apnea but no heart failure saw no significant change in their already normal LVEF.¹² An earlier trial showed even more impressive gains, with LVEF climbing from 25% to nearly 34% after CPAP in heart failure patients with obstructive sleep apnea.¹³ If you snore heavily, wake gasping, or feel exhausted despite sleeping long enough, getting tested for sleep apnea could be one of the highest-yield steps you take.

When a Reversible Cause Is Behind the Drop

Some conditions tank LVEF temporarily but are fully reversible once the trigger is removed. These are worth knowing about because the treatment strategy looks completely different from chronic heart failure management.

Tachycardia-induced cardiomyopathy happens when a sustained fast heart rhythm weakens the heart muscle over weeks or months. Atrial fibrillation, atrial flutter, and other arrhythmias are common culprits. Once the fast rhythm is controlled or eliminated, the heart typically bounces back. In one study of patients who underwent catheter ablation for their arrhythmia, LVEF improved from about 37% to about 59% on average, with nearly 90% of patients achieving normal function within three months.¹⁴ Even rate control without ablation improved or normalized ejection fraction within six months.¹⁵ The key diagnostic clue is a persistently fast or irregular heart rate paired with a low ejection fraction in someone without an obvious structural cause.

Takotsubo cardiomyopathy, sometimes called broken-heart syndrome or stress cardiomyopathy, is triggered by intense emotional or physical stress and causes sudden, dramatic drops in LVEF. The good news is that it usually resolves on its own. LVEF typically recovers rapidly in the first days and continues improving over weeks, with half of patients recovering within about 25 days in one study.¹⁶ Serial imaging confirms that both LVEF and more sensitive measures of heart muscle strain improve continuously from the acute phase through the subacute phase.¹⁷ Younger patients and those with an identifiable triggering event tend to recover faster.

Revascularization and Cardiac Devices

When coronary artery disease is the cause of low LVEF, part of the heart muscle may be “hibernating,” meaning it’s alive but not contracting because blood supply is inadequate. Restoring blood flow through bypass surgery or stenting can wake that tissue up. In patients with confirmed hibernating heart muscle, coronary artery bypass grafting improved LVEF from about 24% to about 30%, while medically treated patients with the same condition actually got worse, declining from about 26% to about 21%.¹⁸ The catch is that the improvement depends on having viable heart muscle rather than scar tissue. In another study, only hearts with confirmed hibernating muscle showed early recovery after surgery, with ejection fraction improving from about 39% to 50%.¹⁹ Viability testing with specialized imaging is how doctors determine whether you’re a candidate for revascularization aimed at improving LVEF.

Cardiac resynchronization therapy (CRT) uses a specialized pacemaker to coordinate the contractions of the left and right ventricles, which can fall out of sync in heart failure. By restoring that synchrony, CRT can improve LVEF, reduce symptoms, and lower mortality.²⁰ CRT works best in patients who have a wide QRS complex on their electrocardiogram, particularly those with a left bundle branch block pattern. Not everyone responds equally: roughly a third of CRT recipients are considered “super-responders” whose LVEF normalizes, while some see little benefit. Careful patient selection is what makes or breaks this therapy.

Why Stopping Medications After Recovery Is Risky

One of the most important and counterintuitive facts about LVEF improvement is that a recovered number does not mean the underlying disease is cured. The TRED-HF trial tested what happens when people with recovered dilated cardiomyopathy gradually stop their heart failure medications. Within six months, 44% of patients who withdrew treatment relapsed, compared with none of those who stayed on their drugs. When the group that had initially stayed on treatment then tried stopping, about 36% relapsed within the next six months.²¹

This trial reshaped how cardiologists think about recovered heart failure. Your LVEF may look normal on a scan, but the medications are often the reason it looks normal. Stopping them lets the old remodeling process restart. The standard approach now is to continue guideline-directed medications indefinitely even after LVEF has returned to normal, unless there is a clearly reversible cause like tachycardia-induced cardiomyopathy or Takotsubo where the trigger has been fully resolved.

CoQ10 and Other Supplements

Coenzyme Q10 (CoQ10) has more supporting evidence than most supplements in heart failure. It helps mitochondria produce energy, and levels are often depleted in heart failure patients. The Q-SYMBIO trial demonstrated a reduction in major adverse cardiovascular events with CoQ10 supplementation in heart failure.²² A meta-analysis of randomized controlled trials found that CoQ10 modestly improved LVEF and increased the distance patients could walk in six minutes, while also reducing hospitalizations and all-cause mortality.²³

A recent trial tested combining high-intensity interval training with different supplement regimens. Patients who received a combination of creatine, D-ribose, CoQ10, and vitamin E alongside exercise showed substantially greater gains in LVEF and walking capacity than a group receiving a simpler supplement mix.²⁴ These results are intriguing but early-stage. CoQ10 is generally safe and inexpensive, which makes it a reasonable addition to standard therapy for many patients, but it should be viewed as a complement to medications and exercise, not a replacement.

Your LVEF Number Depends on How It’s Measured

Before you panic over a specific LVEF reading, understand that measurement variability is real. Two-dimensional echocardiography, the most commonly used method, tends to underestimate LVEF compared with cardiac MRI. In one study, 2D echo readings were on average about 3.7 points lower than MRI readings, and at the clinically important 50% threshold, there was disagreement between the two methods in about 9% of patients.²⁵ Three-dimensional echo performed somewhat better, landing closer to MRI values.

This has practical implications. If you’re tracking your LVEF over time, try to use the same imaging modality each time. A jump from 40% to 45% is meaningful if both measurements came from the same type of echo using the same machine. But if the first was a 2D echo and the second was an MRI, some of that apparent improvement might just reflect the difference in how the two tests measure. Similarly, a “borderline” LVEF on echo might actually be normal on MRI. If a treatment decision hinges on whether your LVEF is above or below a specific cutoff, it’s worth discussing with your cardiologist whether a cardiac MRI would give a more definitive answer.

Stress Reduction and Mental Health

Chronic psychological stress activates the same neurohormonal pathways that heart failure medications are designed to suppress. Cortisol and adrenaline drive up heart rate, constrict blood vessels, and promote the remodeling that lowers LVEF over time. A randomized trial of a meditation and mindfulness program in patients with chronic heart failure found significant improvements in perceived stress, quality of life, sleep quality, and the distance walked in six minutes compared with a control group.²⁶ While this trial focused on functional and quality-of-life outcomes rather than LVEF directly, the walking-distance improvement suggests genuine cardiovascular benefit. Stress management is unlikely to replace any medication, but for someone already doing everything else right, it fills a gap that pills and exercise don’t fully cover.

Emerging Approaches

Remote hemodynamic monitoring is changing how heart failure is managed between clinic visits. Implantable sensors and wearable devices can detect rising pressures in the heart and lungs before symptoms worsen, allowing medication adjustments that keep patients out of the hospital.²⁷ These devices don’t directly improve LVEF, but by enabling tighter medication optimization, they support the kind of steady drug titration that leads to cardiac recovery.

Stem cell therapy for heart failure has been under investigation for over two decades. The premise is that since the heart has limited ability to regenerate muscle on its own, injecting stem cells could replace damaged tissue or stimulate repair.²⁸ Results so far have been disappointing relative to early hopes. Many trials showed modest or no improvements in LVEF, and some of the early positive findings have not been replicated. The field has shifted toward understanding which cell types and delivery methods might work, but stem cell therapy for LVEF improvement remains experimental and is not part of standard treatment.

Heart Failure With Preserved Ejection Fraction Is a Different Problem

Everything discussed above applies to heart failure with reduced ejection fraction, where the heart muscle is too weak to pump effectively. But roughly half of heart failure patients have a normal or near-normal LVEF and instead suffer from a stiff heart that doesn’t fill properly. This condition has different demographics, different underlying structural changes, and a different prognosis than reduced-ejection-fraction heart failure.²⁹ Patients with a normal LVEF and heart failure tend to have more hypertension and less coronary disease, and their hearts are thicker rather than dilated.³⁰

If your doctor tells you that you have heart failure but your LVEF is normal, the goal isn’t to raise the number further. Instead, treatment focuses on managing blood pressure, reducing fluid overload, and addressing the stiffness. The distinction matters because people sometimes assume any heart failure diagnosis means a weak heart, when in fact it may mean a heart that squeezes fine but can’t relax enough to fill. Knowing which type you have determines the entire treatment strategy.